SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-015230
Filing Date
2024-02-14
Accepted
2024-02-14 16:15:15
Documents
14
Period of Report
2024-02-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K adpt-20240214.htm   iXBRL 8-K 46313
2 EX-99.1 adpt-ex99_1.htm EX-99.1 251745
3 GRAPHIC img119828894_0.jpg GRAPHIC 7887
  Complete submission text file 0000950170-24-015230.txt   441876

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT adpt-20240214.xsd EX-101.SCH 29671
15 EXTRACTED XBRL INSTANCE DOCUMENT adpt-20240214_htm.xml XML 4544
Mailing Address 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address 1165 EASTLAKE AVE E SEATTLE WA 98109 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

IRS No.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38957 | Film No.: 24638377
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)